Showing 7031-7040 of 9327 results for "".
- Cosmo, Glenmark Sign Distribution and License Agreements for Winlevi in Europe and South Africahttps://practicaldermatology.com/news/cosmo-glenmark-sign-distribution-and-license-agreements-for-winlevi-in-europe-and-south-africa/2462024/Glenmark Pharmaceuticals Ltd., now has exclusive rights to commercialize Winlevi (clascoterone cream 1%) in 15 EU countries (Bulgaria, the Czech Republic, Denmark, Finland, France, Hungary, Iceland, the Netherlands, Norway, Poland, Portugal,
- Revealed: Why Skin Feels “Tight” After Using a Facial Cleanserhttps://practicaldermatology.com/news/revealed-why-skin-feels-tight-after-using-a-facial-cleanser/2462023/Some cleansers make the skin feel “tight” and some moisturizers make the skin feel “soft,” but exactly why this occurs hasn't been fully understood. To find out, Reinhold H. Dauskardt, the Ruth G. and William K. Bowes Professor in Stanford’s
- Encouraging Preclinical Results Seen for Scinai’s NanoAbs in Plaque Psoriasishttps://practicaldermatology.com/news/encouraging-preclinical-results-seen-for-scinais-nanoabs-in-plaque-psoriasis/2462006/Scinai Immunotherapeutics Ltd.’s anti‑interleukin 17 (IL‑17) NanoAbs downregulated key molecular markers that are overexpressed in plaque psoriasis, according to preclinical data relased by Scinai. Results from ex-vivo study in human psoriatic skin anticipated in Q4 2023; In-
- Tik Tok Trend Watch: Cyanide as a Potential Acne Cure?https://practicaldermatology.com/news/tik-tok-trend-watch-cyanide-as-a-potential-acne-cure/2461968/Tik Tok is where many trends and DIY challenges get started, and skin care one of the more popular categories for this content. The latest -- a viral video of a woman claiming that she has been 'secretly' feeding her boyfriend seeds containing cyanide (yes, that cyani
- POCN Launches AD Center of Excellencehttps://practicaldermatology.com/news/pocn-launches-ad-center-of-excellence/2461965/
- The Dermatology Foundation, Skin of Color Society Partner to Offer Sanofi-Regeneron DEI Mid-Career Awardhttps://practicaldermatology.com/news/the-dermatology-foundation-skin-of-color-society-partner-to-offer-sanofi-regeneron-dei-mid-career-award/2461952/The Dermatology Foundation (DF) and the
- Arctiva’s Eczema Cream Scores NEA Seal of Acceptancehttps://practicaldermatology.com/news/arctivas-eczema-cream-scores-nea-seal-of-acceptance/2461946/
- Bristol Myers Squibb’s New Sotyktu Campaign Reveals the Plain Truth About Living With Moderate to Severe Plaque Psoriasishttps://practicaldermatology.com/news/bristol-myers-squibbs-new-clear-understanding-campaign-reveals-the-plain-truth-about-living-with-moderate-to-severe-plaque-psoriasis/2461914/Bristol Myers Squibb is rolling
- AD Pipeline Watch: Apogee Therapeutics, Inc.’s IL-13 Blocker Enters Phase 1 Trialhttps://practicaldermatology.com/news/ad-pipeline-watch-apogee-therapeutics-incs-il-13-blocker-enters-phase-1-trial/2461911/The first volunteers have been dosed in a Phase 1 trial for
- Replimune, Incyte Enter Into Clinical Trial Collaboration And Supply Agreement To Evaluate RP1 and INCB99280 in CSCChttps://practicaldermatology.com/news/replimune-incyte-enter-into-clinical-trial-collaboration-and-supply-agreement-to-evaluate-rp1-and-incb99280-in-cscc/2461908/Replimune Group, Inc. and Incyte are collaborating to a study RP1 in combination with INCB99280, Incyte’s small molecule oral PD-L1 inhibitor, in cutaneous squamous cell carcinoma (CSCC) and in other cancer types,